Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
PL8177 / Palatin Technologies
NCT04105452: Study to Evaluate PL8177 in Subjects With Non Infectious Uveitis (NIU)	Not yet recruiting	2	40	NA	PL8177	Palatin Technologies	Non-infectious Uveitis	05/20	09/20
2019-003197-24: Study of the effect of PL-8177 on inflammatory onset and resolution in Healthy Volunteers	Not yet recruiting	2	45	Europe	prednisolone, PL8177, Solution for injection in pre-filled syringe, Tablet, Prednisolone Tablets BP 5mg	Palatin Technologies, Inc., Palatin Technologies, Inc.	Inflammatory Onset and Resolution, Blister induction and effect of PL8177 on inflammation, Body processes [G] - Immune system processes [G12]
PL8177-205, NCT05466890: Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC)	Recruiting	2	28	US	PL8177 Placebo, Placebo, PL8177, Active study medication	Palatin Technologies, Inc	Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative, Ulcerative Colitis Flare	04/24	08/24